VITAL SIGNS IN PATIENTS WITH BRONCHIAL ASTHMA

Authors

  • Mutaljonov Muhammadjon Omonali o'g'li ADTI Terapiya yo'nalishi magistratura 3 bosqich Author

Keywords:

Asthma, Emergencies, Monitoring, Physiologic, Vital Signs.

Abstract

Bronchial asthma is a chronic respiratory condition characterized by reversible airway obstruction, inflammation, and bronchial hyperresponsiveness. While vital signs are crucial indicators of a patient's overall health, they play a particularly significant role in assessing and managing patients with bronchial asthma.

References

Kotwani A, Chhabra SK. Effect of patient education and standard treatment guidelines on asthma control: an intervention trial. WHO South East Asia J Public Health 2012;

American Lung Association. Asthma Risk Factors American Lung Association [Internet]. 2018. Available fro m: ht tps:/ /www .lun g.or g/l ung-h ealt h-a nd-diseas es/ lun g-d ise ase-lookup /as thm a/a sthma-symptoms-causes-risk-factors/asthma-risk-factors.

Global Asthma Network. The Global Asthma Report. Vol 5. Auckland, New Zealand 2018.

Couillard S, Steyerberg E, Beasley R, Pavord I. Blood eosinophils, fractional exhaled nitric oxide and the risk of asthma attacks in randomised controlled trials: protocol for a systemic review and control arm patient-level meta-analysis for clinical prediction modelling.

Fletcher M, van Der Molen T, Lenney W, Boucot I, Aggarwal B, Pizzichini E. Primary Care Management of Asthma Exacerbations or Attacks: Impact of the COVID-19 Pandemic. Adv Ther [I nternet] 2022;

Couillard S, Laugerud A, Jabeen M, Ramakrishnan S, Melhorn J, Hinks T, et al. Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide.

Couillard S, Do WIH, Beasley R, Hinks TS, Pavord ID. Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE). ERJ Open Res

Published

2024-03-15